Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Parkinson’s disease is primarily distinguished by resting tremors, bradykinesia, muscle rigidity, and balance issues, all of which have a substantial influence on patients' quality of life. Although ...

Parkinson's Disease: Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa in Parkinson's patients, potentially leading to ...